Suppr超能文献

利用CRISPR/Cas9敲除刚地弓形虫中的亮氨酸氨肽酶。

Knockout of leucine aminopeptidase in Toxoplasma gondii using CRISPR/Cas9.

作者信息

Zheng Jun, Jia Honglin, Zheng Yonghui

机构信息

Harbin Veterinary Research Institute, CAAS-Michigan State University Joint Laboratory of Innate Immunity, State Key Laboratory of Veterinary Biotechnology, Chinese Academy of Agricultural Sciences, Maduan Street 427, Nangang District, Harbin 150001, PR China.

Harbin Veterinary Research Institute, CAAS-Michigan State University Joint Laboratory of Innate Immunity, State Key Laboratory of Veterinary Biotechnology, Chinese Academy of Agricultural Sciences, Maduan Street 427, Nangang District, Harbin 150001, PR China.

出版信息

Int J Parasitol. 2015 Feb;45(2-3):141-8. doi: 10.1016/j.ijpara.2014.09.003. Epub 2014 Nov 13.

Abstract

Leucine aminopeptidases of the M17 peptidase family represent ideal drug targets for therapies directed against the pathogens Plasmodium, Babesia and Trypanosoma. Previously, we characterised Toxoplasma gondii leucine aminopeptidase and demonstrated its role in regulating the levels of free amino acids. In this study, we evaluated the potential of T. gondii leucine aminopeptidase as a drug target in T. gondii by a knockout method. Existing knockout methods for T. gondii have many drawbacks; therefore, we developed a new technique that takes advantage of the CRISPR/Cas9 system. We first chose a Cas9 target site in the gene encoding T. gondii leucine aminopeptidase and then constructed a knockout vector containing Cas9 and the single guide RNA. After transfection, single tachyzoites were cloned in 96-well plates by limiting dilution. Two transfected strains derived from a single clone were cultured in Vero cells, and then subjected to expression analysis by western blotting. The phenotypic analysis revealed that knockout of T. gondii leucine aminopeptidase resulted in inhibition of attachment/invasion and replication; both the growth and attachment/invasion capacity of knockout parasites were restored by complementation with a synonymously substituted allele of T. gondii leucine aminopeptidase. Mouse experiments demonstrated that T. gondii leucine aminopeptidase knockout somewhat reduced the pathogenicity of T. gondii. An enzymatic activity assay showed that T. gondii leucine aminopeptidase knockout reduced the processing of a leucine aminopeptidase-specific substrate in T. gondii. The absence of leucine aminopeptidase activity could be slightly compensated for in T. gondii. Overall, T. gondii leucine aminopeptidase knockout influenced the growth of T. gondii, but did not completely block parasite development, virulence or enzymatic activity. Therefore, we conclude that leucine aminopeptidase would be useful only as an adjunctive drug target in T. gondii.

摘要

M17肽酶家族的亮氨酸氨肽酶是针对疟原虫、巴贝斯虫和锥虫等病原体的治疗的理想药物靶点。此前,我们对刚地弓形虫亮氨酸氨肽酶进行了表征,并证明了其在调节游离氨基酸水平方面的作用。在本研究中,我们通过基因敲除方法评估了刚地弓形虫亮氨酸氨肽酶作为刚地弓形虫药物靶点的潜力。现有的刚地弓形虫基因敲除方法存在许多缺点;因此,我们开发了一种利用CRISPR/Cas9系统的新技术。我们首先在编码刚地弓形虫亮氨酸氨肽酶的基因中选择了一个Cas9靶点,然后构建了一个包含Cas9和单向导RNA的敲除载体。转染后,通过有限稀释法在96孔板中克隆单个速殖子。将来自单个克隆的两个转染菌株在Vero细胞中培养,然后通过蛋白质印迹法进行表达分析。表型分析表明,刚地弓形虫亮氨酸氨肽酶的敲除导致附着/侵袭和复制受到抑制;通过用刚地弓形虫亮氨酸氨肽酶的同义替换等位基因进行互补,敲除寄生虫的生长和附着/侵袭能力均得以恢复。小鼠实验表明,刚地弓形虫亮氨酸氨肽酶敲除在一定程度上降低了刚地弓形虫的致病性。酶活性测定表明,刚地弓形虫亮氨酸氨肽酶敲除减少了刚地弓形虫中亮氨酸氨肽酶特异性底物的加工。在刚地弓形虫中,亮氨酸氨肽酶活性的缺失可得到轻微补偿。总体而言,刚地弓形虫亮氨酸氨肽酶敲除影响了刚地弓形虫的生长,但并未完全阻断寄生虫的发育、毒力或酶活性。因此,我们得出结论,亮氨酸氨肽酶仅作为刚地弓形虫的辅助药物靶点有用。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验